← Insiders

THC

Bearish signalScored 2026-09-27 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.

Research, not advice.

À propos

Tenet Healthcare Corporation

Nom
Tenet Healthcare Corporation
Secteur
Healthcare
Industrie
Medical - Care Facilities
Bourse
NYSE
Capitalisation
$21.6B
Employés
88,500
PDG
Saumya Sutaria
Site web
https://www.tenethealth.com
Marché
ARDTCONCYHFSNUYHCARMYHY

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.

Price (1 year)

Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.

VENTE TOTALE: 132 484 titres (~36 138 216,30 $ US)

Insiders
KERREY J ROBERTMARK RICHARD JWest NadjaHANEY CECIL DSutaria SaumyaRomo TammyBlunt Roy
Total bought
—

Avg buy (VWAP, 90d window) —

Total sold
$32,247,326

Avg sell (VWAP, 90d window) $265.97 vs last close $253.97 (-4.5%)

Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.

Last activity
2026-09-14
Liquidity
Liquid $193,531,870/day · 20d vol
Last synced
2026-10-01 21:10:58 Synced via automated research pipeline

Sign in to request a sync of this company's price history and timing levels.

Insider holdings as a share of total assets aren't available for this company.

Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.

Recent Form 4

Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.

Date Person Side Shares Price Value Form 4
2026-09-14 KERREY J ROBERT Sell · S 2,502 $264.62 $662,079 Form 4
2026-09-10 MARK RICHARD J Sell · S 10,000 $263.42 $2,634,200 Form 4
2026-09-02 West Nadja Sell · S 1,152 $258.80 $298,138 Form 4
2026-08-31 Foo Lisa Y Sell · S 24,000 $266.32 $6,391,680 Form 4
2026-08-25 Sutaria Saumya Sell · S 7,899 $275.26 $2,174,279 Form 4
2026-08-24 HANEY CECIL D Sell · S 1,300 $278.03 $361,439 Form 4
2026-08-24 Sutaria Saumya Sell · S 36,656 $278.90 $10,223,358 Form 4
2026-08-07 Romo Tammy Sell · S 2,500 $260.83 $652,075 Form 4
2026-08-06 Romo Tammy Sell · S 4,922 $264.15 $1,300,146 Form 4
2026-08-05 Blunt Roy Sell · S 600 $262.68 $157,608 Form 4
2026-07-29 Foo Lisa Y Sell · S 10,000 $258.03 $2,580,300 Form 4
2026-07-27 Arbour Paola M Sell · S 10,878 $243.90 $2,653,144 Form 4
2026-07-27 BIERMAN JAMES L Sell · S 5,000 $244.96 $1,224,800 Form 4
2026-07-27 Lynch Christopher S. Sell · S 3,837 $243.44 $934,079 Form 4

Congressional trades

STOCK Act disclosures (90-day window)

Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.

No STOCK Act disclosures for this company in this window.

Recent trades

DateRepresentativeTypeAmount
2026-04-20Jonathan JacksonSale (Full)$15,001 - $50,000
2026-04-15Jonathan JacksonSale (Full)$1,001 - $15,000
2026-02-11Jonathan JacksonSale (Partial)$1,001 - $15,000
2025-12-10Jonathan JacksonPurchase$15,001 - $50,000
2025-09-03Jonathan JacksonPurchase$1,001 - $15,000
2025-08-04Lisa C. McClainSale (Full)$1,001 - $15,000
2025-06-11Lisa C. McClainPurchase$1,001 - $15,000
2024-09-04John JamesSale (Full)$1,001 - $15,000
2023-11-10John JamesPurchase$1,001 - $15,000

Signal

Bearish signalScored 2026-09-27 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.

THC shows a solid liquidity profile and improved cash flow efficiency (liquidity score: 80), but the fundamental trend score (65) is weighed down by margin compression, high leverage, and heavy intangible asset exposure.

The first sentence of the analysis written for THC on 2026-09-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Bearish signal Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.

Factor checklist — research, not advice

A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.

  • Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
  • Congress Pulls against a bullish reading. STOCK Act sale disclosures outnumber purchases
  • Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
  • Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
  • Financial indicators Supports a bullish reading. Current ratio 1.76 · operating margin 16%

Suggested stop 249.77, nearest stored support minus 0.5 ATR(1.6% under the last close). Reward/risk to the next stored resistance is 4.83. Research, not advice. Not an order.

Market snapshot

Financial ratios

MetricTrend2025-12-312024-12-312023-12-312022-12-312021-12-31
Gross Profit Margin82.3%39.7%38.0%36.8%37.3%
Ebit Margin17.0%29.4%12.3%11.7%14.4%
Ebitda Margin21.0%33.4%16.5%16.0%18.8%
Operating Profit Margin16.1%28.8%12.2%12.2%14.7%
Pretax Profit Margin13.1%25.4%7.9%7.0%9.7%
Continuous Operations Profit Margin11.1%19.7%6.4%5.2%7.6%
Net Profit Margin6.6%15.5%3.0%2.1%4.7%
Bottom Line Profit Margin6.6%15.5%2.9%2.2%4.7%
Current Ratio1.7591.7821.5061.3361.385
Quick Ratio1.6811.7021.4191.2461.310
Solvency Ratio0.1100.1970.0650.0560.076
Cash Ratio0.6460.7000.2580.1920.463
Price To Earnings Ratio12.7303.82312.57412.7069.554
Price To Earnings Growth Ratio-0.2410.0090.223-0.2310.076
Forward Price To Earnings Growth Ratio-0.2410.0090.223-0.2310.076
Price To Earnings Diluted Ratio12.8293.86013.23512.8739.702
Price To Earnings Diluted Growth Ratio-0.2440.0080.261-0.2340.078
Price To Book Ratio4.2452.9334.7774.5688.489
Price To Sales Ratio0.8410.5920.3740.2720.448
Price To Free Cash Flow Ratio7.08110.9614.73316.2539.590
Price To Operating Cash Flow Ratio5.0615.9763.2354.8175.566
Debt To Assets Ratio0.4440.4950.5300.5550.567
Debt To Equity Ratio3.1213.4359.33013.20415.220
Debt To Capital Ratio0.7570.7750.9030.9300.938
Long Term Debt To Capital Ratio0.7560.7530.9020.9290.938
Financial Leverage Ratio7.0326.93717.60723.77926.828
Working Capital Turnover Ratio6.3077.15210.50511.0489.135
Operating Cash Flow Ratio0.7930.4750.4990.2420.307
Operating Cash Flow Sales Ratio0.1660.0990.1160.0560.080
Free Cash Flow Operating Cash Flow Ratio0.7150.5450.6840.2960.580
Debt Service Coverage Ratio4.5015.0873.0192.6403.077
Interest Coverage Ratio4.1897.2112.7862.6213.111
Short Term Operating Cash Flow Coverage Ratio44.8106.91619.7837.46911.615
Operating Cash Flow Coverage Ratio0.2690.1430.1580.0720.100
Capital Expenditure Coverage Ratio3.5052.1993.1611.4212.383
Dividend Paid And Capex Coverage Ratio3.5052.1993.1611.4212.383
Dividend Payout Ratio0.0000.0000.0000.0000.000
Enterprise Value Multiple6.2903.4166.3336.3196.004

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 82.3% ▲42.5% ▲35.5%
Ebit Margin 17.0% ▼-12.4% ▲0.1%
Ebitda Margin 21.0% ▼-12.3% ▼-0.1%
Operating Profit Margin 16.1% ▼-12.7% ▼-0.7%
Pretax Profit Margin 13.1% ▼-12.3% ▲0.5%
Continuous Operations Profit Margin 11.1% ▼-8.6% ▲1.1%
Net Profit Margin 6.6% ▼-8.9% ▲0.2%
Bottom Line Profit Margin 6.6% ▼-8.9% ▲0.2%
Current Ratio 1.759 ▼-0.024 ▲0.205
Quick Ratio 1.681 ▼-0.021 ▲0.209
Solvency Ratio 0.110 ▼-0.087 ▲0.009
Cash Ratio 0.646 ▼-0.054 ▲0.194
Price To Earnings Ratio 12.730 ▲8.908 ▲2.453
Price To Earnings Growth Ratio -0.241 ▼-0.250 ▼-0.208
Forward Price To Earnings Growth Ratio -0.241 ▼-0.250 ▼-0.208
Price To Earnings Diluted Ratio 12.829 ▲8.969 ▲2.329
Price To Earnings Diluted Growth Ratio -0.244 ▼-0.252 ▼-0.218
Price To Book Ratio 4.245 ▲1.312 ▼-0.757
Price To Sales Ratio 0.841 ▲0.249 ▲0.335
Price To Free Cash Flow Ratio 7.081 ▼-3.880 ▼-2.643
Price To Operating Cash Flow Ratio 5.061 ▼-0.915 ▲0.130
Debt To Assets Ratio 0.444 ▼-0.051 ▼-0.074
Debt To Equity Ratio 3.121 ▼-0.314 ▼-5.741
Debt To Capital Ratio 0.757 ▼-0.017 ▼-0.103
Long Term Debt To Capital Ratio 0.756 ▲0.004 ▼-0.099
Financial Leverage Ratio 7.032 ▲0.095 ▼-9.404
Working Capital Turnover Ratio 6.307 ▼-0.845 ▼-2.523
Operating Cash Flow Ratio 0.793 ▲0.318 ▲0.330
Operating Cash Flow Sales Ratio 0.166 ▲0.067 ▲0.063
Free Cash Flow Operating Cash Flow Ratio 0.715 ▲0.170 ▲0.151
Debt Service Coverage Ratio 4.501 ▼-0.586 ▲0.837
Interest Coverage Ratio 4.189 ▼-3.022 ▲0.205
Short Term Operating Cash Flow Coverage Ratio 44.810 ▲37.895 ▲26.692
Operating Cash Flow Coverage Ratio 0.269 ▲0.126 ▲0.120
Capital Expenditure Coverage Ratio 3.505 ▲1.306 ▲0.971
Dividend Paid And Capex Coverage Ratio 3.505 ▲1.306 ▲0.971
Dividend Payout Ratio 0.000 0.000 0.000
Enterprise Value Multiple 6.290 ▲2.874 ▲0.618

Key metrics

MetricTrend20252024202320222021
Market cap$17.91B$12.23B$7.68B$5.22B$8.73B
Enterprise value$28.20B$23.54B$21.45B$19.44B$22.01B
EV / Sales1.32x1.14x1.04x1.01x1.13x
EV / Op. cash flow7.97x11.50x9.04x17.95x14.04x
EV / Free cash flow11.15x21.09x13.22x60.55x24.19x
EV / EBITDA6.29x3.42x6.33x6.32x6.00x
Net debt / EBITDA2.29x1.64x4.07x4.62x3.62x
Current ratio1.76x1.78x1.51x1.34x1.39x
Income quality2.52x0.50x1.81x1.08x1.06x
Graham number$128$179$46$30$43
Graham net-net-$174-$154-$185-$177-$171
Tax burden50.2%61.0%37.8%30.6%48.4%
Interest burden77.3%86.4%64.2%60.2%67.2%
Working capital$3.39B$3.37B$2.41B$1.50B$1.97B
Invested capital$23.38B$22.55B$21.40B$20.64B$20.15B
Return on assets4.7%11.1%2.2%1.5%3.3%
Operating ROA11.7%20.8%9.1%8.5%10.5%
Return on tangible assets8.2%19.0%3.7%2.6%5.4%
Return on equity33.3%76.7%38.0%36.0%88.9%
Return on invested capital11.5%18.5%8.6%7.6%9.9%
Return on capital employed13.6%24.2%10.7%10.3%12.8%
Earnings yield7.9%26.2%8.0%7.9%10.5%
Free cash flow yield14.1%9.1%21.1%6.2%10.4%
Capex / Op. cash flow28.5%45.5%31.6%70.4%42.0%
Capex / Depreciation114.0%113.8%86.3%90.6%77.0%
Capex / Sales4.7%4.5%3.7%4.0%3.4%
SG&A / Sales40.8%42.6%2.0%2.1%2.1%
R&D / Sales0.0%0.0%0.0%0.0%0.0%
Stock comp / Sales0.5%0.3%0.3%0.3%0.3%
Intangibles / Total assets42.3%41.8%41.2%42.5%39.0%
Days sales outstanding44d54d60d66d62d
Days payables outstanding131d38d40d45d39d
Operating cycle78d64d72d78d73d
Cash conversion cycle-54d26d32d33d35d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.

Change over 1 year

Valuation
Market cap ▲+46.5%EV / Sales ▲+16.2%EV / EBITDA ▲+84.1%EV / Op. cash flow ▼-3.533Earnings yield ▼-0.183Graham number ▼-50.620
Profitability
Return on equity ▼-0.434Return on assets ▼-0.063Return on invested capital ▼-0.070Return on capital employed ▼-0.105Operating ROA ▼-0.091Income quality ▲+2.012Tax burden ▼-0.107
Efficiency
Days sales outstanding ▼-10.008Days payables outstanding ▲+93.404Operating cycle ▲+13.456Cash conversion cycle ▼-79.949Capex / Sales ▲+0.002R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.024Net debt / EBITDA ▲+0.654Working capital ▲+14000000.000Invested capital ▲+835000000.000Intangibles / Total assets ▲+0.005

Change over 5 years

Valuation
Market cap ▲+105.3%EV / Sales ▲+17.2%EV / EBITDA ▲+4.8%EV / Op. cash flow ▼-6.070Earnings yield ▼-0.026Graham number ▲+85.174
Profitability
Return on equity ▼-0.556Return on assets ▲+0.014Return on invested capital ▲+0.016Return on capital employed ▲+0.009Operating ROA ▲+0.012Income quality ▲+1.454Tax burden ▲+0.018
Efficiency
Days sales outstanding ▼-17.996Days payables outstanding ▲+92.483Operating cycle ▲+4.135Cash conversion cycle ▼-88.348Capex / Sales ▲+0.014R&D / Sales n/a
Balance-sheet strength
Current ratio ▲+0.374Net debt / EBITDA ▼-1.329Working capital ▲+1420000000.000Invested capital ▲+3228000000.000Intangibles / Total assets ▲+0.033

Employee count

Peer market caps

Recent news